Related Experiment Video
Updated: May 18, 2026
09:57
A Facile and Efficient Approach for the Production of Reversible Disulfide Cross-linked Micelles
Published on: December 23, 2016
Reduction-sensitive tioguanine prodrug micelles.
André J van der Vlies1, Urara Hasegawa, Jeffrey A Hubbell
1Institute of Bioengineering, School of Life Sciences and School of Engineering, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
Molecular Pharmaceutics
|September 8, 2012
Summary
Researchers developed novel tioguanine prodrug micelles using block copolymers. These micelles effectively release the anticancer drug tioguanine in response to biological cues, showing potential for targeted cancer therapy.
Area of Science:
- Polymer Chemistry
- Nanomedicine
- Drug Delivery
Background:
- Colloidal drug conjugates offer unique targeting for tumor vasculature and lymphatic systems.
- Tioguanine prodrugs are explored for anticancer and immunosuppressive applications, including cancer immunotherapy.
- Block copolymers of poly(ethylene glycol)-bl-poly(propylene sulfide) can self-assemble into micelles.
Purpose of the Study:
- To synthesize novel prodrug block copolymers by linking tioguanine to poly(ethylene glycol)-bl-poly(propylene sulfide) via a reduction-sensitive disulfide bond.
- To characterize the self-assembly of these copolymers into tioguanine prodrug micelles.
- To evaluate the drug release kinetics and bioactivity of the released tioguanine.
Main Methods:
- Synthesis of tioguanine prodrug block copolymers through disulfide exchange reaction.
- Characterization of micelle formation and size (18-40 nm) using spectroscopic data.
- In vitro assessment of tioguanine release in response to cysteine and serum.
- Evaluation of tioguanine bioactivity in cultured cells.
Main Results:
- Successfully synthesized tioguanine prodrug block copolymers that self-assemble into micelles.
- Demonstrated tioguanine release from micelles triggered by cysteine and serum.
- Showed that tioguanine release rate is controllable by adjusting the poly(propylene sulfide) block length.
- Confirmed the bioactivity of released tioguanine against cultured cells.
Conclusions:
- Developed a novel system of tioguanine prodrug micelles with tunable drug release properties.
- The synthesized micelles maintain the bioactivity of tioguanine, indicating potential for targeted cancer therapy.
- The poly(propylene sulfide) block length is a key factor in controlling the release rate of tioguanine.
